Banner

Alpha Mannosidosis Global Market Report 2023 – By Therapy Type (Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT), Gene Therapy), By Indication (Type I, Type II, Type III), By End User (Hospitals, Speciality Clinics) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : h1214 | Delivery Time: 2-3 business days | Format :


Alpha mannosidosis refers to a rare genetic disorder defined by the body's cells' inability to adequately break down specific groups of complex sugars. Numerous bodily organs and systems, including the central nervous system, are impacted by sugar buildup. The disease's effects might vary greatly from person to person.

The main types of therapy for alpha mannosidosis are bone marrow transplant (BMT), enzyme replacement therapy (ERT), peripheral blood stem cell transplantation (PBSCT) and gene therapy. A bone marrow transplant is a procedure in which dysfunctional marrow is replaced with healthy marrow. Enzyme replacement therapy includes replacing a defective enzyme in people who are lacking or deficient in that enzyme. Peripheral blood stem cell transplantation is a procedure in which the patient whose stem cells have been destroyed by disease or by radiation or high doses of anticancer drugs, receives healthy stem cells. Gene therapy is a procedure in which DNA is introduced to a patient to treat a genetic disease. The different types of indications include Type I, Type II and Type III and are implemented in a wide range of verticals such as hospitals and speciality clinics.

The alpha mannosidosis market research report is one of a series of new reports from The Business Research Company that provides alpha mannosidosis market statistics, including alpha mannosidosis industry global market size, regional shares, competitors with a alpha mannosidosis market share, detailed alpha mannosidosis market segments, market trends and opportunities, and any further data you may need to thrive in the alpha mannosidosis industry. This alpha mannosidosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global alpha mannosidosis market size grew from $10.59 billion in 2022 to $12.65 billion in 2023 at a compound annual growth rate (CAGR) of 19.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The alpha mannosidosis market size is expected to grow to $24.27 billion in 2027 at a CAGR of 17.7%.

The increasing investments in research are expected to contribute to the growth of the alpha mannosidosis market in the forecast period. Currently, in the alpha mannosidosis market, only one company has therapies for rare genetic diseases. However, several firms have products in the clinical stages, which will boost market demand in the forecast period. For instance, in 2020, the EU clinical trials database lists 39,219 clinical trials with a EudraCT protocol, 6,426 of which are clinical trials involving subjects under the age of 18. Therefore, the increasing investments in research fuel the growth of the alpha mannosidosis market.

The advancements in treatment for alpha mannosidosis like pharmacological therapy are gaining traction in the alpha mannosidosis market. For instance, in 2018 – Chiesi Group, an international research-focused Healthcare company, announced that it has received a positive opinion recommending the marketing authorization of Velmanase Alfa, under the brand name Lamzede from the European Medicines Agency Committee for Medicinal Products for Human Use. Lamzede is an enzyme replacement therapy intended to provide or supplement natural alpha-mannosidase, an enzyme that helps with the degradation of mannose–rich oligosaccharides and thus prevents their accumulation in various tissues in the body.

Major players in the alpha mannosidosis market are Chiesi Farmaceutici S.p.A., Nuo Therapeutics, and Zymenex.

North America was the largest region in the alpha mannosidosis market in 2022. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the alpha mannosidosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the alpha mannosidosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The alpha mannosidosis market includes revenues earned by entities by intellectual disability, skeletal abnormalities, hearing loss, and muscle weakness. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

 The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global alpha mannosidosis market is segmented -

1) By Therapy Type: Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT), Gene Therapy

2) By Indication: Type I, Type II, Type III

3) By End-User: Hospitals, Speciality Clinics

    Table Of Contents

    1. Executive Summary

    2. Alpha Mannosidosis Market Characteristics

    3. Alpha Mannosidosis Market Trends And Strategies

    4. Alpha Mannosidosis Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Alpha Mannosidosis Market

    4.2. Ukraine-Russia War Impact On Alpha Mannosidosis Market

    4.3. Impact Of High Inflation On Alpha Mannosidosis Market

    5. Alpha Mannosidosis Market Size And Growth

    5.1. Global Alpha Mannosidosis Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Alpha Mannosidosis Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Alpha Mannosidosis Market Segmentation

    6.1. Global Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Bone Marrow Transplant (BMT)

    Enzyme Replacement Therapy (ERT)

    Peripheral Blood Stem Cell Transplantation (PBSCT)

    Gene Therapy

    6.2. Global Alpha Mannosidosis Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Type I

    Type II

    Type III

    6.3. Global Alpha Mannosidosis Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals

    Speciality Clinics

    7. Alpha Mannosidosis Market Regional And Country Analysis

    7.1. Global Alpha Mannosidosis Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Alpha Mannosidosis Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Alpha Mannosidosis Market

    8.1. Asia-Pacific Alpha Mannosidosis Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Alpha Mannosidosis Market

    9.1. China Alpha Mannosidosis Market Overview

    9.2. China Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Alpha Mannosidosis Market

    10.1. India Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Alpha Mannosidosis Market

    11.1. Japan Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Alpha Mannosidosis Market

    12.1. Australia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Alpha Mannosidosis Market

    13.1. Indonesia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Alpha Mannosidosis Market

    14.1. South Korea Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Alpha Mannosidosis Market

    15.1. Western Europe Alpha Mannosidosis Market Overview

    15.2. Western Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Alpha Mannosidosis Market

    16.1. UK Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Alpha Mannosidosis Market

    17.1. Germany Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Alpha Mannosidosis Market

    18.3. France Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Alpha Mannosidosis Market

    19.1. Eastern Europe Alpha Mannosidosis Market Overview

    19.2. Eastern Europe Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Alpha Mannosidosis Market

    20.1. Russia Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Alpha Mannosidosis Market

    21.1. North America Alpha Mannosidosis Market Overview

    21.2. North America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Alpha Mannosidosis Market

    22.1. USA Alpha Mannosidosis Market Overview

    22.2. USA Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Alpha Mannosidosis Market

    23.1. South America Alpha Mannosidosis Market Overview

    23.2. South America Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Alpha Mannosidosis Market

    24.1. Brazil Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Alpha Mannosidosis Market

    25.1. Middle East Alpha Mannosidosis Market Overview

    25.2. Middle East Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Alpha Mannosidosis Market

    26.1. Africa Alpha Mannosidosis Market Overview

    26.2. Africa Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Alpha Mannosidosis Market Competitive Landscape And Company Profiles

    27.1. Alpha Mannosidosis Market Competitive Landscape

    27.2. Alpha Mannosidosis Market Company Profiles

    27.2.1. CHIESI Farmaceutici SpA

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Nuo Therapeutics

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. XX

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. XX

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. XX

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Alpha Mannosidosis Market

    29. Alpha Mannosidosis Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Alpha Mannosidosis Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Alpha Mannosidosis Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Alpha Mannosidosis Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Alpha Mannosidosis Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: China, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: India, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: Japan, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: Australia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: Indonesia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: South Korea, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Western Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: UK, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Germany, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: France, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Eastern Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Russia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: North America, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: USA, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: South America, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Brazil, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Middle East, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Africa, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: CHIESI Farmaceutici SpA Financial Performance
  • Table 28: Nuo Therapeutics Financial Performance
  • Table 29: XX Financial Performance
  • Table 30: XX Financial Performance
  • Table 31: XX Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Alpha Mannosidosis Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Alpha Mannosidosis Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Alpha Mannosidosis Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Alpha Mannosidosis Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: China, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: India, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: Japan, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: Australia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: Indonesia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: South Korea, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Western Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: UK, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Germany, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: France, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Eastern Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Russia, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: North America, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: USA, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: South America, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Brazil, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Middle East, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Africa, Alpha Mannosidosis Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: CHIESI Farmaceutici SpA Financial Performance
  • Figure 28: Nuo Therapeutics Financial Performance
  • Figure 29: XX Financial Performance
  • Figure 30: XX Financial Performance
  • Figure 31: XX Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report